Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01349946 · ClinicalTrials.gov registry record
Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 138
- Enrollment target
NCT01349946: Completed study, sponsored by Stanford University.
NCT01349946 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01349946 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution Study 2 (DEFUSE 2) is a multi-center pilot study to determine if cerebral perfusion imaging can help identify which patients, who are ineligible for intravenous tissue plasminogen activator (iv tPA) therapy or have failed iv tPA therapy, are most likely to benefit from an endovascular clot removal procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01349946
The ClinicalTrials.gov registry entry for NCT01349946 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01349946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01349946 about?
NCT01349946 is a clinical study titled "Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)". Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution Study 2 (DEFUSE 2) is a multi-center pilot study to determine if cerebral perfusion imaging can help identify which patients, who are ineligible for intravenous tissue plasminogen activator (iv tPA) therapy or have failed ...
What is the current status of trial NCT01349946?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2008-06. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01349946?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.